Dahlquist Karl S.
SEC CIK 1861996 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ATRC | AtriCure, Inc. | CLO | 87.3K | — | $1.36M | 24 | 2021-06-30 | 2026-08-24 |
Most active insiders at ATRC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WEHRWEIN SVEN | Dir | — | $1.32M |
| 2 | Privitera Salvatore | Chief Technical Off | — | $879.8K |
| 3 | Doraiswamy Vinayak | CSO | — | $523.1K |
| 4 | Dahlquist Karl S. | CLO | — | $458.1K |
| 5 | Noznesky Justin J | Chief Mktg, Strategy Off | — | $432.5K |
| 6 | GROVES REGINA E | Dir | — | $288.1K |
| 7 | Yuen Maggie | Dir | — | $241.6K |
| 8 | Prange Karen | Dir | — | $224.2K |
| 9 | Nachman Shlomo | Dir | — | — |
| 10 | Telman Deborah H | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-26 06:50 | 2026-08-24 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | S - Sale | $48.89 | -9,370 | 87.3K | -10% | -$458.1K | |
| 2026-07-02 09:03 | 2026-06-30 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $23.78 | +636 | 96.7K | +0.7% | +$15.1K | |
| M | 2026-03-03 | 2026-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $0.00 | +43.2K | 96.5K | +81% | $0 |
| 2026-03-03 | 2026-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | F - Tax | $31.26 | -15.7K | 96.1K | -14% | -$490.4K | |
| 2025-07-02 | 2025-06-30 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $25.84 | +822 | 68.6K | +1% | +$21.2K | |
| 2025-03-04 | 2025-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | F - Tax | $38.74 | -9,870 | 67.7K | -13% | -$382.4K | |
| M | 2025-03-04 | 2025-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $0.00 | +25.9K | 77.6K | +50% | $0 |
| 2024-07-02 | 2024-06-28 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $19.35 | +707 | 51.7K | +1% | +$13.7K | |
| 2024-03-20 | 2024-03-18 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | S - Sale | $32.16 | -1,885 | 51.0K | -4% | -$60.6K | |
| 2024-03-07 | 2024-03-05 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | S - Sale | $37.36 | -8,231 | 52.8K | -13% | -$307.5K | |
| M | 2024-03-05 | 2024-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $0.00 | +30.3K | 52.8K | +134% | $0 |
| 2023-11-03 | 2023-11-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | S - Sale | $34.43 | -1,248 | 30.8K | -4% | -$43.0K | |
| 2023-07-28 | 2023-07-26 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | S - Sale | $57.09 | -3,417 | 32.0K | -10% | -$195.1K | |
| 2023-07-03 | 2023-06-30 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $38.11 | +557 | 35.5K | +2% | +$21.2K | |
| 2023-06-07 | 2023-06-06 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | S - Sale | $47.03 | -1,422 | 34.9K | -4% | -$66.9K | |
| 2023-05-03 | 2023-05-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | S - Sale | $44.83 | -4,417 | 36.3K | -11% | -$198.0K | |
| 2023-03-03 | 2023-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | F - Tax | $38.81 | -6,894 | 40.7K | -14% | -$267.6K | |
| M | 2023-03-03 | 2023-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $0.00 | +24.1K | 31.5K | +327% | $0 |
| 2022-07-05 | 2022-06-30 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $34.73 | +350 | 23.5K | +2% | +$12.2K | |
| M | 2022-03-03 | 2022-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $0.00 | +14.6K | 23.6K | +162% | $0 |
| 2022-03-03 | 2022-03-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | F - Tax | $69.59 | -7,299 | 23.1K | -24% | -$507.9K | |
| 2022-01-04 | 2021-12-31 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $59.10 | +24 | 15.8K | +0.2% | +$1,418 | |
| 2021-07-02 | 2021-07-01 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | S - Sale | $79.53 | -336 | 15.8K | -2% | -$26.7K | |
| 2021-07-02 | 2021-06-30 | ATRC | AtriCure, Inc. | Dahlquist Karl S. | CLO | A - Grant | $45.72 | +428 | 16.1K | +3% | +$19.6K |
Purchase Sale Sale after option exercise All abbreviations